About
Basic Data Updated:
2 months agoThe Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 cr and a paid-up capital of Rs 5.11 cr.
The Corporate currently has active open charges totaling ₹18.59 Lakh.
Nurjahan Shaik, Trimurthulu Guna, and Mitra Puchhalapalli serve as directors at the Company.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U01110TG2001PTC036979 |
| Company No. | 036979 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 05 Jul 2001 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Financials of Genova Biotechniques Private Limited
Genova Biotechniques Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 34.06% increase. The company also saw a substantial improvement in profitability, with a 48.88% increase in profit. The company's net worth dipped by a decrease of 5.69%.
Corporate Structure
Unlock access to Genova Biotechniques's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Genova Biotechniques Private Limited
Unlock and access historical data on people associated with Genova Biotechniques, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
MP
Mitra Puchhalapalli
Managing DirectorAppointment Date: 05-Jul-2001
Status: Current
Board Members(2)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Mar 2021 | ₹1.86 M | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genova Biotechniques, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genova Biotechniques's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
11 years 8 months Recent activity within the organization
Annual General Meeting
Genova Biotechniques Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Balance Sheet
Genova Biotechniques Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Director Appointment
Nurjahan Shaik was appointed as a Additional Director was appointed as a Additional Director on 06 Jan 2023 & has been associated with this company since 1 year 8 months .
06 Jan 2023Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.19 cr with Charge ID 100443977 was registered on 25 Mar 2021.
25 Mar 2021Director Appointment
Trimurthulu Guna was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 02 Nov 2009 & has been associated with this company since 14 years 10 months .
02 Nov 2009
Recent News, Updates & Announcement
Tasly unit invests 50M in Chinese diabetes play Genova.Genova Biotech Co Ltd Changzhou China received a x2450 million investment from an undisclosed subsidiary of Tasly Holdings Group Co Ltd Shanghai.
Biocentury 09 Dec 2017
Frequently asked questions
What is the Incorporation or founding date of Genova Biotechniques Private Limited?
